Cite

HARVARD Citation

    Bagel, J. et al. (2017). Open‐label study of etanercept treatment in patients with moderate‐to‐severe plaque psoriasis who lost a satisfactory response to adalimumab. British journal of dermatology. pp. 411-418. [Online]. 
  
Back to record